START FREE VISIT

$1350/month | free shipping

OZEMPIC®

Stay fuller longer with weekly Ozempic® injections

Controls appetite & reduces cravings

Ozempic® is not FDA-approved for weight loss, but may be prescribed if a provider deems it appropriate

GET STARTED

Ozempic®

Starting at $1,350/month

IMPORTANT SAFETY INFORMATION & COMMON SIDE EFFECTS

Ozempic® should be used with a reduced-calorie meal plan and increased physical activity.

Ozempic® contains semaglutide and should not be used with other GLP-1 receptor agonist medicines, or any other products containing semaglutide.

Most Common Ozempic® Side Effects

The most common side effects of Ozempic® include nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar) in patients with type 2 diabetes, flatulence (gas buildup), gastroenteritis (an intestinal infection) and gastroesophageal reflux disease (a type of digestive disorder).

The above is only a summary. For a full list of possible side effects, and other important safety information, 
click here.

Other Important Safety Information 

Ozempic® is FDA approved to treat type 2 diabetes. Approval for treatment is not guaranteed. Eligibility and approval is always at the discretion of the prescriber, who will determine eligibility based on an assessment of your complete health profile.

Do not use Ozempic® if you are allergic to semaglutide or any of its ingredients.

Do not use Ozempic® if you are currently pregnant, breastfeeding or plan to become pregnant or breastfeed.

Do not use Ozempic® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC), or if you have an endocrine system condition called multiple endocrine neoplasia syndrome type 2 (MEN 2).

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamines, and herbal supplements. Ozempic® may affect the way some medicines work and some medicines may affect the way Ozempic® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin.

The above is only a summary. For a full list of important safety information, 
click here.

Note: This product alone is not intended to diagnose, treat, cure, or prevent any disease. Please consult a medical professional to determine whether or not Ozempic® is appropriate for you.

IMPORTANT SAFETY INFORMATION & COMMON SIDE EFFECTS

Copyright 2023 by AgelessRx

OUR OFFERINGS

LEARN

CONTACT US

650-503-9990info@agelessrx.comExplore All TreatmentsExplore NAD+ SupportLongevity ConsultationBio Age TestLongevity ScienceOur BlogTestimonialsHow We WorkAboutFAQs
CareersPrivacy PolicyTerms & Conditions
Longevity Quiz

OZEMPIC®

Stay fuller longer with weekly Ozempic® injections

Controls appetite & reduces cravings

Ozempic® is not FDA-approved for weight loss, but may be prescribed if a provider deems it appropriate

$1350/month | free shipping

GET STARTED

OZEMPIC® BENEFITS

Do More, Age Less

  • FDA approved for type 2 diabetes

  • Administered once weekly via self-injection*

  • Convenient injection pen with pre-dialed doses

  • Shown to reduce cardiometabolic risk factors

  • Improves blood pressure & cholesterol††

  • Lowers blood sugar & A1c levels††

  • Used with reduced-calorie meal plan & exercise for best results

Do More, Age Less

  • Promotes cellular energy production.

  • Supports DNA health and repair.

  • Required to “turn off” genes that accelerate degenerative aging processes.

  • NAD+ is a required “helper” molecule for proteins that regulate other cellular functions. 

OZEMPIC BENEFITS®

FAQs

What is Ozempic®?

Ozempic® is a semaglutide-based medication that is FDA approved to treat type 2 diabetes. Clinical trials have also demonstrated that Ozempic®, as well as semaglutide medications like Wegovy® (also manufactured by Novo Nordisk), can reduce weight, regulate appetite, and lower cardiovascular risk factors.

How does Ozempic® work?

The active ingredient in Ozempic® is semaglutide. Semaglutide falls into a category of medications known as GLP-1 receptor agonists (GLP-1 RAs), which imitate the GLP-1 hormone to reduce the amount of glucose delivered into the bloodstream and encourage more insulin production from your pancreas. GLP-1 RAs also act on the digestive system to delay gastric emptying, thereby delaying the release of food from the stomach, and modulate brain activity to suppress appetite.

What’s the difference between Ozempic® & Wegovy®?

Both medications are GLP-1s (glucagon-like receptor agonists) and contain the same active ingredient (semaglutide). Since the two drugs have the same active ingredient, it is fair to ask: is Wegovy® the same as Ozempic®?

Wegovy® and Ozempic® are the same medications, sold under different brand names. The main differences are the amount of semaglutide in each pen (the dosage) and the prescribed use for each, as well as the guided titration schedule: Ozempic® is FDA approved for type 2 diabetes, with a target dosage of 2.0mg, while Wegovy® is FDA approved for weight loss, with a target dosage of 2.4mg.

Ozempic® is considered a safe and reliable alternative for Wegovy®, with many users reporting consistent outcomes. Historically, Ozempic® has also been prescribed when Wegovy® supplies are limited.

SEE ALL FAQS

How It Works

START FREE VISIT

Ozempic treats type 2 diabetes but may be prescribed off-label for weight loss, if appropriate. Ozempic may have serious side effects, including possible thyroid tumors. Do not use if you or your family have a history of a type of thyroid cancer called MTC or MEN 2. Read more about serious warnings and safety info.
*Medication is prescribed only if appropriate. Your prescriber will approve or disapprove an Ozempic prescription at their discretion after careful consideration of your unique health profile. 

As reported in NY Times & Healthline.

†† As noted in the 68-week clinical trial published in NEJM, 2021.


Stay current on research updates, latest products and special offers